Medicare Enrolled
Dr. Sharad Vora, MD
Pulmonary Disease · Cary, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Vora from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vora?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Vora
Dr. Sharad Vora is a pulmonary disease specialist in Cary, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Vora performed 3,983 Medicare services across 2,824 unique beneficiaries.
Between the years covered by Open Payments, Dr. Vora received a total of $2,410 from 17 pharmaceutical and/or device companies across 47 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Vora is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 6% volume in NC
$2,410 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,983
Medicare services
Top 6% in NC for pulmonary disease
2,824
Unique beneficiaries
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~199 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
708 | $92 | $259 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
390 | $27 | $108 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
390 | $39 | $106 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
389 | $39 | $105 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
331 | $47 | $122 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
319 | $36 | $134 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
259 | $65 | $128 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
215 | $129 | $367 |
| New patient office visit, complex (60-74 min) | 135 | $157 | $449 |
| Principal care management for high-risk disease, first 30 minutes This service involves 30 minutes of personal care management by a qualified healthcare professional for a patient with a single high-risk disease, billed per calendar month. |
110 | $61 | $215 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
94 | $24 | $65 |
| Chronic care management services Comprehensive assessment and care planning for patients requiring ongoing chronic care management. |
79 | $46 | $125 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
64 | $29 | $50 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
62 | $74 | $75 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
59 | $96 | $250 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
44 | $24 | $70 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
43 | $451 | $1,211 |
| Additional 30 minutes of principal care management This service covers an additional 30 minutes of care management for a single high-risk disease, provided personally by a qualified healthcare professional each calendar month. |
39 | $44 | $241 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
37 | $132 | $389 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
37 | $60 | $139 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
33 | $14 | $26 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
31 | $61 | $225 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
26 | $90 | $200 |
| Additional chronic care management time, 60 minutes This service covers an additional 60 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions, billed per calendar month. |
25 | $48 | $111 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
20 | $471 | $1,270 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
18 | $13 | $30 |
| Complex chronic care management, first 60 minutes This service involves clinical staff time directed by a healthcare professional to manage two or more chronic conditions over a calendar month. It covers the first 60 minutes of this coordinated care effort. |
14 | $95 | $137 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
12 | $208 | $490 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$2,410
Total received (2018-2024)
Avg $344/year across 7 years
Top 47% in NC for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
17
Companies
47
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,376 (98.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$34 (1.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$677
2023
$410
2022
$285
2021
$230
2020
$103
2019
$91
2018
$613
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$509
Corcept Therapeutics
$78
Avadel CNS Pharmaceuticals, LLC
$29
Regeneron Healthcare Solutions, Inc.
$25
INOGEN, INC.
$21
Amgen Inc.
$15
Top 3 companies account for 91.0% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,342
Olympus Corporation of the Americas
$573
Corcept Therapeutics
$78
Philips Electronics North America Corporation
$65
GENZYME CORPORATION
$61
GlaxoSmithKline, LLC.
$44
Regeneron Healthcare Solutions, Inc.
$43
Mylan Specialty L.P.
$39
Avadel CNS Pharmaceuticals, LLC
$29
INOGEN, INC.
$21
SANOFI-AVENTIS U.S. LLC
$20
United Therapeutics Corporation
$20
Teva Pharmaceuticals USA, Inc.
$19
Amgen Inc.
$15
ARBOR PHARMACEUTICALS, INC.
$15
Sunovion Pharmaceuticals Inc.
$13
Boehringer Ingelheim Pharmaceuticals, Inc.
$12
Top 3 companies account for 82.7% of all-time payments
Associated products mentioned in payments ›
(6299) DreamWear · AIRSUPRA · AirDuo Digihaler · BREZTRI · DUPIXENT · EVIS EXERA · FASENRA · Horizant · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · Korlym · LUMRYZ · NUCALA · STIOLTO RESPIMAT · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · Trilogy 100 · Utibron · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
57
Per 100K population
5.0
County median income
$101,763
Nearest hospital
WAKEMED, CARY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Vora is a clinical cardiology specialist, with above-average Medicare volume (top 6% in NC), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Vora experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Vora performed 708 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Vora receive payments from pharmaceutical companies?
Yes. Dr. Vora received a total of $2,410 from 17 companies across 47 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vora's costs compare to other pulmonary diseases in Cary?
Dr. Vora's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vora) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Cary
Browse pulmonary diseases in Cary ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NC
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NC
Which NC pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Olympus Corporation of the Americas Payments to Doctors
See all physicians who received payments from Olympus Corporation of the Americas.
By company
Corcept Therapeutics Payments to Doctors
See all physicians who received payments from Corcept Therapeutics.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology